ミズーリ州における心不全の臨床試験
ミズーリ州内の拠点で、心不全に関する40件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
ELEVATE-HFpEF Clinical Study
- Saint Lukes Mid America Heart Institute, Kansas City
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Columbia
- Research Site, Kansas City
- Research Site, Kansas City
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/10/02更新 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Kansas City VA Medical Center, Kansas City
- St. Louis Heart and Vascular, P.C., St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City
- St. Louis Heart and Vascular, P.C., St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06424288A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Washington University School of Medicine, St Louis
被験者募集中第2相
40歳〜84歳 · 全性別 · 2026/09/30更新 · NCT06979362A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Bridgeton
- Research Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Saint Luke's Hospital of Kansas City, Kansas City
- Washington University Center for Advanced Medicine, St Louis
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06736574Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
- Saint Luke's Hospital of Kansas City, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/09/23更新 · NCT07232030A Study of LY3971297 in Participants With Heart Failure
- Washington University, St Louis
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/09/22更新 · NCT07547540Alleviant ALLAY-HFrEF Study
- Washington University - St Louis, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/09/16更新 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Saint Luke's Hospital of Kansas City, Kansas City
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Columbia
- Research Site, Kansas City
- Research Site, Kansas City
- 他1件
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/15更新 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10002 Kansas City, MO Investigative Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06024746The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
- St. Luke's Hospital of Kansas City, Kansas City
被験者募集中観察研究
22歳以上 · 全性別 · 2026/09/10更新 · NCT07098858A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Kansas City, MO Investigative Site 10002, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- WashU Medicine, St Louis
被験者募集中
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 145, Kansas City
- Local Institution - 109, St Louis
被験者募集中第2相
30歳〜84歳 · 全性別 · 2026/08/31更新 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Washington University-Pediatric Cardiology/ St. Louis Children's Hospital ( Site 0006), St Louis
被験者募集中第2/3相
29 Days – 17 Years · 全性別 · 2026/08/28更新 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Washington University Center for Advanced Medicine, St Louis
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/08/27更新 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Columbia
- Kansas City
- St Louis
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/20更新 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/19更新 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Kansas City
- Tenax Investigational Site, St Louis
被験者募集中第3相
18歳〜85歳 · 全性別 · 2026/08/19更新 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Clinical Research Consultants, JCCT Co, Kansas City
- Washington University, St Louis
- Amicis Centers of Clinical Research, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07567001Alleviant ALLAY-HF Study
- Washington University - St Louis, St Louis
被験者募集中
40歳以上 · 全性別 · 2026/08/14更新 · NCT05685303Assessment of CCM in HF With Higher Ejection Fraction
- St. Louis Heart and Vascular, Bridgeton
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/08/06更新 · NCT05064709Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- Washington Univ School Of Medicine, St Louis
被験者募集中第3相
2歳〜11歳 · 全性別 · 2026/07/24更新 · NCT06597006A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/10更新 · NCT06033950A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
被験者募集中第3相
18歳以下 · 全性別 · 2026/06/29更新 · NCT07192952PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- St. Lukes/ Mid-American Heart Institute, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
- Washington University - St. Louis Children's Hospital - Cardiology, St Louis
被験者募集中第3相
6 Months – 17 Years · 全性別 · 2026/06/15更新 · NCT07188805Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- St. Luke's Hospital, Kansas City
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
- University of Missouri-Columbia, Columbia
被験者募集中観察研究健康なボランティア歓迎
18歳〜100歳 · 全性別 · 2026/05/07更新 · NCT07083557The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
- Washington University School of Medicine, St Louis
被験者募集中第2相
19歳〜79歳 · 全性別 · 2026/05/06更新 · NCT05562167CCM OPEN HF Registry
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/23更新 · NCT07112924The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- St. Louis Heart and Vascular, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Washington University, St Louis
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- Washington University - Barnes Jewish Health Hospital, St Louis
被験者募集中
18歳以上 · 全性別 · 2026/03/18更新 · NCT06895070Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
- University of Mossouri, Columbia
被験者募集中第4相
18歳以上 · 全性別 · 2025/09/18更新 · NCT06964464HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Saint Luke's Health System, Kansas City
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2024/05/22更新 · NCT06425848Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- Washington University in Saint Louis, St Louis
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2024/03/26更新 · NCT04703842ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。